DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

The COVID-19 pandemic has thrust the medical device industry into an unprecedented situation, forcing medical regulatory bodies and health agencies to enact extraordinary measures in order to ensure a strong response to local COVID-19 transmission while maintaining the continuity of health care services in a safe and efficient manner.

In addition to highlighting current and anticipated challenges and considering the long-term impact of the COVID-19 pandemic, this E-Book outlines how regulators and agencies in the US, Europe, and the Asia Pacific region are adapting to the situation, particularly in order to:

  • Mitigate infection risks,
  • Facilitate access to essential medical products,
  • Remove undue regulatory burdens,
  • Support affected economic operators, and
  • Improve digital health capabilities